Publications by authors named "M Lebwohl"

Claim this Profile
L
Laboratory monitoring in patients with moderate to severe plaque psoriasis.
Jonathan M Fenkel, John A Osborne, April W Armstrong, Bruce Strober, Linda Stein Gold, Mark Lebwohl

J Dermatolog Treat· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimekizumab Impact on Patient-Reported Outcomes in Plaque Psoriasis: 4-Year Results from BE SURE, BE VIVID, BE READY, and BE BRIGHT.
April Armstrong, Kim A Papp, Mark Lebwohl, Laura J Savage, Keiichi Yamanaka

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 Year.
Diamant Thaçi, Akihiko Asahina, Wolf-Henning Boehncke, Alice B Gottlieb, Mark Lebwohl

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When Profit Shapes Prescriptions: The Dilemma of Insurer-Driven Biologic Switching.
Dev Patel, Kateryna Karpoff, Mark Lebwohl

J Am Acad Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Patterns of Patients with Basal Cell Carcinoma Using Sonidegib and Vismodegib: Discontinuation Rates and Clinical Conditions During Treatment.
Mark G Lebwohl, Darrell S Rigel, Zeynep Eroglu, Victoria E Barghout, Deepshekhar Gupta

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis